Table 1.
Diverse actions of NO in cancer: tumor promoting role of NO
Tumor promoting role | |
---|---|
Role of nitric oxide (NO) | Mechanism by which NO acts |
Genotoxicmechanisms |
Formation of toxic and mutagenic species |
Direct modification of DNA– strand breaks, oxidation and deamination of nucleic acids | |
Inhibition of systems required to repair DNA lesions | |
Antiapoptotic effects |
GC to AT mutations in p53– loss of its repressor activity |
Direct inhibition of caspase activity through s-nitrosylation of the cysteine thiol | |
Inhibition of cytochrome C release | |
Increase in Bcl-2 expression | |
Suppression of ceramide generation | |
Activation of cyclooxygenase | |
Induces and promotes angiogenesis (iNOSandeNOS) |
Dilatation of arteriolar vessels by eNOS |
VEGF release and NO stimulation of hyperpermeability of vascular endothelium | |
Increased production of PGE2 resulting in increased tumor vasculature permeability | |
|
Activation of COX-2 which stimulates production of proangiogenic factors and prostaglandins |
Limits host immune response against tumor |
Suppression of proliferation and infiltration of leukocytes |
Low leukocyte-endothelial interaction | |
Promotes metastasis | Promotes lymphangiogenesis and spread to lymph nodes possibly through involvement of VEGF-C |
Upregulation of MMP-2 and −9 | |
Downregulation of TIMP-2 and-3 |